Our Partnering Interests

Our innovation goal is to ensure we remain at the forefront of science and technology and achieve our ambition of continuously delivering meaningful breakthroughs that improve patients’ lives. This means working closely with all stakeholders in the innovation ecosystem – from pharma to biotechs to academia to starts ups. With industry-leading levels of R&D investment totaling 20 billion euro we look forward to increasing our growing global community of innovation partners so together we can more effectively meet the healthcare challenges of the future.

Our partnering activities encompass:

Focusing on the discovery and development of new and/or better medications for patients in our areas of therapeutic focus

Identifying and exploring dynamic research fields such as immune modulation which may impact and create synergies across our therapeutic areas

Harnessing emerging science and technology within and beyond our therapeutic areas – Research Beyond Borders.

*Investment designated 2025